SAN DIEGO, April 30, 2019 /PRNewswire/ -- Evofem
Biosciences, Inc., (NASDAQ: EVFM) will hold a conference call
to discuss financial results and business highlights for the first
quarter ended March 31, 2019, as
follows:
Date
|
Tuesday, May 7,
2019
|
Time
|
11:00 a.m.
EDT
|
Dial-in
numbers
|
(866) 503-5561 (U.S.
toll-free) or (253) 336-2965
|
Passcode
|
9851099
|
Webcast (live and
archived)
|
www.evofem.com under
"Investors" or click here
|
The teleconference replay will be available approximately two
hours after completion through Sunday, May 12, 2019,
at (855) 859-2056 (U.S.) or (404) 537-3406
(International). The replay access code is 9851099. The
archived webcast will be available via the aforementioned
URLs.
About Evofem Biosciences
Evofem Biosciences, Inc., is
a clinical-stage biopharmaceutical company committed to developing
and commercializing innovative products to address unmet needs in
women's sexual and reproductive health. Evofem Biosciences aims to
advance the lives of women by developing innovative solutions, such
as woman-controlled contraception and potential protection from
certain sexually transmitted infections ("STIs"). The Company
is leveraging its proprietary Multipurpose Vaginal pH Regulator™
(MVP-R) platform to develop Amphora® (L-lactic
acid, citric acid and potassium bitartrate) for birth control and
prevention of urogenital acquisition of certain STIs. For more
information, please visit www.evofem.com.
Amphora® is a registered trademark and Multipurpose
Vaginal pH Regulator™ is a trademark of Evofem Biosciences,
Inc.
Contact
Amy Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
C: (917) 673-5775
View original content to download
multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-to-report-first-quarter-2019-results-and-provide-corporate-update-on-may-7-2019-300840367.html
SOURCE Evofem Biosciences, Inc.